COURTNEY SERINI: Open Payments
NPI 1154043289 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,720 in 166 payments from 15 companies in 2025. Trend: 2023 $966 · 2024 $1,573 · 2025 $2,720
Food & beverage: $2,616Education: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $480 |
| Regeneron Healthcare Solutions, Inc. | 16 | $383 |
| Janssen Biotech, Inc. | 29 | $300 |
| UCB, Inc. | 17 | $253 |
| GENZYME CORPORATION | 8 | $228 |
| Incyte Corporation | 15 | $219 |
| PFIZER INC. | 10 | $191 |
| Amgen Inc. | 11 | $179 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $148 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Bimzelx, OPZELURA, EUCRISA, OTEZLA, RINVOQ.
Industry payments across MI — which companies pay providers there.
